- Seeking Alpha•2 years ago
Investment thesis Investment in Chelsea Therapeutics ( CHTP ) presents a very asymmetric risk/return opportunity. On 7th of May, the company announced a merger agreement and going private transaction with ...
- Motley Fool•2 years ago
A small-cap buyout, the initiation of a nearly 4% dividend yield, strong late-stage psoriasis data for a big pharma duo, and a small-cap disaster "du jour" are this week's must-know stories in ...
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|